angiotensin
- Managing hypertension in cardiology practice according to risk profile.
- Exploring the Potential of Angiotensin II Antagonists in Cardiovascular Management.
- The Role of AT1 Receptor Antagonists in Vascular and Renal Protection: An Evolving Paradigm.
- Setting New Standards for the AII Antagonist Class.
- Innovations in the Management of the Hypertensive Patient in 2008.
- Angiotensin II antagonists –therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy.
- Prevention and Treatment of Stroke in Patients with Hypertension.
- AII antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartan.
- Role of Angiotensin II in Cardiovascular Disease – Therapeutic Implications of More Than a Century of Research.
- Review of the molecular pharmacology of losartan and its possible relevance to stroke prevention in patients with hypertension.
- Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
- Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
- Do Angiotensin II Antagonists Provide Benefits Beyond Blood Pressure Reduction?
- Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.
